Production and characterization of monoclonal antibodies against pregnancy-associated plasma protein A

Molecular Human Reproduction

Volumn 5, Issue 7, 1999, Pages 675-681

  Bersinger, N A ^a   Meisser, A ^b   Bessou, T ^c   Seguin, P ^c   Birkhauser M H ^a   Bischof, P ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c CIS Bio International   (France)

Author keywords

Down's syndrome; Monoclonal antibodies; Pregnancy associated plasma protein A (PAPP A)

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; MONOCLONAL ANTIBODY; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ANTIBODY PRODUCTION; ARTICLE; DOWN SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC SCREENING; HUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN PURIFICATION; TRISOMY 21;

ARMORACIA RUSTICANA;

EID: 0032981110     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/5.7.675     Document Type: Article

References (24)

1. Berry, E., Aitken, D.A., Crossley, J.A. et al. (1997) Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimesters. Br. J. Obstet. Gynaecol., 104, 811-817.
2. Bersinger, N.A., Brizot, M.L., Johnson, A. et al. (1994) First trimester maternal serum pregnancy-associated plasma protein A and pregnancy-specific β1-glycoprotein in fetal trisomies. Br. J. Obstet. Gynaecol., 101, 970-974.
3. Bersinger, N.A., Marguerat, P., Pescia, G. et al. (1995a) Pregnancy-associated plasma protein A (PAPP-A): measurement by highly sensitive and specific enzyme immunoassay, importance of first-trimester serum determinations, and stability studies. Reprod. Fertil. Dev., 7, 1419-1423.
4. Bersinger, N.A., Zakher, A., Huber, U. et al. (1995b) A sensitive immunoassay for pregnancy-associated plasma protein A (PAPP-A): a possible first trimester method of screening for Down syndrome and other trisomies. Arch. Gynecol. Obstet., 256, 185-192.
5. Bersinger, N.A. (1996) Détermination de la PAPP-A du sérum maternel par ELISA pour la détection de la trisomie foetale au premier trimestre. Reprod. Hum. Horm., 7, 429-134.
6. Bersinger, N.A., Altermatt, H.J., Birkhäuser, M.H. et al. (1997) Non-placental production of pregnancy-associated plasma protein A (PAPP-A): old and new evidence. Early Preg. Biol. Med., 3, 96-101.
7. Bersinger, N.A., Leporrier, N., Herrou, M. et al. (1999) Maternal serum pregnancy-associated plasma protein A (PAPP-A) but not pregnancy-specific β1-glycoprotein (SP1) is a useful second trimester marker for fetal trisomy 18. Prenat. Diag., 19, 537-541.
8. Bischof, P. (1984) Placental proteins: pregnancy-associated plasma protein A. Contrib. Gynecol. Obstet., 12, 41-73.
9. Bischof, P. and Meisser, A. (1989) Immunological heterogeneity of pregnancy-associated plasma protein A (PAPP-A). Effects on the radioimmunoassay of PAPP-A. Br. J. Obstet. Gynaecol., 96, 870-875.
10. Brambati, B., Tului, L., Bonacchi, I. et al. (1994) Serum PAPP-A and free β-hCG are first-trimester screening markers for Down syndrome. Prenat. Diag., 14, 1043-1047.
11. Bueler, M.R. and Bersinger, N.A. (1989) Antiserum to pregnancy-associated plasma protein A (PAPP-A) recognises human haptoglobin. Br. J. Obstet. Gynaecol., 96, 867-869.
12. Haddow, J.E., Palomaki, G.E., Knight, G.J. et al. (1998) Screening of maternal serum for fetal Down's syndrome in the first trimester. N. Engl. J. Med., 338, 955-961. .
13. Krantz, D.A., Larsen, J.W., Buchanan, P.D. et al. (1996) First-trimester Down syndrome screening: free β-human chorionic gonadotropin and pregnancy-associated plasma protein A. Am. J. Obstet. Gynaecol., 174, 612-616.
14. Lin, T.M., Halbert, S.P., Kiefer, D. et al. (1974) Characterisation of four human pregnancy-associated plasma proteins. Am. J. Obstet. Gynecol., 118, 223-226. .
15. Meisser, A., Geinoz, A. and Bischof, P. (1988) In vitro effects of pregnancy-associated plasma protein A: Artifacts due to heparin. Biol. Reprod., 39, 373-378.
16. Muller, F., Cuckle, H., Teisner, B. et al. (1993) Serum PAPP-A levels are depressed in women with fetal Down's syndrome in early pregnancy. Prenat. Diag., 13, 633-636.
17. Oxvig, C., Sand, O., Kristensen, T. et al. (1993) Circulating human pregnancy-associated plasma protein A is disulfide-bridged to the proform of eosinophil major basic protein. J. Biol. Chem., 268, 12243-12246.
18. Oxvig, C., Sand, O., Kristensen, T. et al. (1994) Isolation and characterisation of circulating complex between human pregnancy-associated plasma protein A and proform of eosinophil major basic protein. Biochim Biophys Acta 1201, 415-423.
19. Sinosich, M.J., Davey, M.W., Ghosh, P. et al. (1982) Specific inhibition of human granulocyte elastase by human pregnancy-associated plasma protein A. Biochem. Int., 5, 777-786. .
20. Sjoberg, J., Wahlstrom, T. and Seppala, M. (1984) Pregnancy-associated plasma protein A in the human endometrium is dependent on the effect of progesterone. J. Clin. Endocrinol. Metab., 58, 359-362.
21. Spencer, K., Aitken, D.A., Crossley, J.A. et al. (1994) First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A. Ann. Clin. Biochem., 31, 447-454.
22. Wheeler, D.M. and Sinosich, M.J. (1998) Prenatal screening in the first trimester of pregnancy. Prenat. Diag., 18, 537-543.
23. Wald, N., Stone, R., Cuckle, H.S. et al. (1992) First trimester concentrations of pregnancy-associated plasma protein A and placental protein 14 in Down's syndrome. Br. Med. J., 305, 28. .
24. Wald, N.J., George, L., Smith, D. et al. (1996) Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. Br. J. Obstet. Gynaecol., 103, 407-412.